It operates by mimicking the natural action of HGH on fat metabolism but without the muscle growth, water retention, or potential side effects associated with HGH use
However, the Phase IIb obesity trial failed to reach statistical significance for its primary weight-loss endpoint
How is AOD-9604 supplied
The study sought to clarify whether AOD-9604 produced its reported fat-reducing effects through the same receptor pathway as native growth hormone, and whether the 3-AR pathway was required for activity
For clinical use, regular monitoring of certain health parameters is advised to ensure safety, especially when addressing specific medical conditions
It is an unapproved investigational compound that did not complete clinical development, has not been authorized by Health Canada for any human or veterinary indication, and is not intended to diagnose, treat, cure, or prevent any disease